Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital

Background. Since the end of December 2019, novel coronavirus- (SARS-CoV-2-) infected pneumonia (COVID-19) has spread rapidly in China. The study was designed to describe the clinical characteristics of COVID-19 patients with and without diabetes in Wuhan. Methods. 199 COVID-19 patients were admitte...

Full description

Saved in:
Bibliographic Details
Main Authors: Guozhen Li, Qin Deng, Jiali Feng, Fang Li, Nian Xiong, Qiong He
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/1652403
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546907773206528
author Guozhen Li
Qin Deng
Jiali Feng
Fang Li
Nian Xiong
Qiong He
author_facet Guozhen Li
Qin Deng
Jiali Feng
Fang Li
Nian Xiong
Qiong He
author_sort Guozhen Li
collection DOAJ
description Background. Since the end of December 2019, novel coronavirus- (SARS-CoV-2-) infected pneumonia (COVID-19) has spread rapidly in China. The study was designed to describe the clinical characteristics of COVID-19 patients with and without diabetes in Wuhan. Methods. 199 COVID-19 patients were admitted to Wuhan Red Cross Hospital in China from January 24th to March 15th. The cases were divided into the diabetic and nondiabetic groups according to the history of taking antidiabetic drugs or by plasma fasting blood glucose level at admission, and the differences between the groups were compared. A multivariable analysis of independent risk factors for in-hospital death was performed. Results. Among 199 COVID-19 patients, 76 were diabetic and 123 were nondiabetic. Compared with nondiabetics, patients with diabetes were older and had high levels of fasting plasma glucose (FPG), D-dimer, white blood cells, blood urea nitrogen (BUN), and total bilirubin (TBIL) and lower levels of lymphocytes, albumin and oxygen saturation (SaO2), and higher mortality (P<0.05). The two groups showed no difference in clinical symptoms. Diabetes (odds ratio (OR): 10.816, 95% CI (confidence interval): 1.895-61.741, P=0.007), higher level of D-dimer at admission (OR: 1.094, 95% CI: 1.017-1.178, P=0.016), and a lymphocyte count<0.6×109/L at admission (OR: 7.609, 95% CI: 1.087-32.049, P=0.006) were associated with increasing odds of death. Antidiabetic drugs were associated with decreasing odds of death. Treatment with low molecular weight heparin was not related to odds of death. Conclusion. The mortality rate of COVID-19 patients with diabetes was significantly higher than those without diabetes. Diabetes, higher level of D-dimer, and a lymphocyte count<0.6×109/L at admission were the risk factors associated with in-hospital death.
format Article
id doaj-art-d7a938e608ff4019a9817dac7a90bf1f
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-d7a938e608ff4019a9817dac7a90bf1f2025-02-03T06:46:40ZengWileyJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/16524031652403Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross HospitalGuozhen Li0Qin Deng1Jiali Feng2Fang Li3Nian Xiong4Qiong He5Department of Gastroenterology, Wuhan Red Cross Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Red Cross Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Red Cross Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Red Cross Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Red Cross Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Red Cross Hospital, Wuhan, ChinaBackground. Since the end of December 2019, novel coronavirus- (SARS-CoV-2-) infected pneumonia (COVID-19) has spread rapidly in China. The study was designed to describe the clinical characteristics of COVID-19 patients with and without diabetes in Wuhan. Methods. 199 COVID-19 patients were admitted to Wuhan Red Cross Hospital in China from January 24th to March 15th. The cases were divided into the diabetic and nondiabetic groups according to the history of taking antidiabetic drugs or by plasma fasting blood glucose level at admission, and the differences between the groups were compared. A multivariable analysis of independent risk factors for in-hospital death was performed. Results. Among 199 COVID-19 patients, 76 were diabetic and 123 were nondiabetic. Compared with nondiabetics, patients with diabetes were older and had high levels of fasting plasma glucose (FPG), D-dimer, white blood cells, blood urea nitrogen (BUN), and total bilirubin (TBIL) and lower levels of lymphocytes, albumin and oxygen saturation (SaO2), and higher mortality (P<0.05). The two groups showed no difference in clinical symptoms. Diabetes (odds ratio (OR): 10.816, 95% CI (confidence interval): 1.895-61.741, P=0.007), higher level of D-dimer at admission (OR: 1.094, 95% CI: 1.017-1.178, P=0.016), and a lymphocyte count<0.6×109/L at admission (OR: 7.609, 95% CI: 1.087-32.049, P=0.006) were associated with increasing odds of death. Antidiabetic drugs were associated with decreasing odds of death. Treatment with low molecular weight heparin was not related to odds of death. Conclusion. The mortality rate of COVID-19 patients with diabetes was significantly higher than those without diabetes. Diabetes, higher level of D-dimer, and a lymphocyte count<0.6×109/L at admission were the risk factors associated with in-hospital death.http://dx.doi.org/10.1155/2020/1652403
spellingShingle Guozhen Li
Qin Deng
Jiali Feng
Fang Li
Nian Xiong
Qiong He
Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital
Journal of Diabetes Research
title Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital
title_full Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital
title_fullStr Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital
title_full_unstemmed Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital
title_short Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital
title_sort clinical characteristics of covid 19 patients with and without diabetes in wuhan red cross hospital
url http://dx.doi.org/10.1155/2020/1652403
work_keys_str_mv AT guozhenli clinicalcharacteristicsofcovid19patientswithandwithoutdiabetesinwuhanredcrosshospital
AT qindeng clinicalcharacteristicsofcovid19patientswithandwithoutdiabetesinwuhanredcrosshospital
AT jialifeng clinicalcharacteristicsofcovid19patientswithandwithoutdiabetesinwuhanredcrosshospital
AT fangli clinicalcharacteristicsofcovid19patientswithandwithoutdiabetesinwuhanredcrosshospital
AT nianxiong clinicalcharacteristicsofcovid19patientswithandwithoutdiabetesinwuhanredcrosshospital
AT qionghe clinicalcharacteristicsofcovid19patientswithandwithoutdiabetesinwuhanredcrosshospital